FdaApplication

BLA 103239

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGlaxoSmithKline Biologicals
application_typeBLA
approval_date1989-08-28

Products (4)

ProductActive ingredientStrengthDosage form
ENGERIX-B—10UG/.5MLInjection
ENGERIX-B—20UG/MLInjection
ENGERIX-B—20UG/MLInjection
ENGERIX-B—10UG/.5MLInjection

4 products